Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Sustainable Growth Advisers LP

Sustainable Growth Advisers LP decreased its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 11.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 632,040 shares of the medical research company's stock after selling 80,166 shares during the period. Thermo Fisher Scientific comprises 1.8% of Sustainable Growth Advisers LP's portfolio, making the stock its 22nd largest holding. Sustainable Growth Advisers LP owned about 0.17% of Thermo Fisher Scientific worth $314,503,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the company. Bernard Wealth Management Corp. purchased a new stake in shares of Thermo Fisher Scientific in the fourth quarter worth $25,000. Ameriflex Group Inc. bought a new stake in Thermo Fisher Scientific during the 4th quarter valued at approximately $30,000. Navigoe LLC bought a new stake in Thermo Fisher Scientific during the 4th quarter valued at approximately $37,000. Smallwood Wealth Investment Management LLC purchased a new position in Thermo Fisher Scientific during the 1st quarter valued at approximately $37,000. Finally, Crowley Wealth Management Inc. bought a new position in Thermo Fisher Scientific during the fourth quarter valued at $43,000. Hedge funds and other institutional investors own 89.23% of the company's stock.

Wall Street Analyst Weigh In

TMO has been the subject of several research reports. Evercore ISI lowered their price objective on shares of Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating for the company in a research report on Tuesday, July 8th. Argus dropped their target price on Thermo Fisher Scientific from $620.00 to $470.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. UBS Group boosted their price objective on Thermo Fisher Scientific from $460.00 to $500.00 and gave the company a "neutral" rating in a report on Thursday. Wall Street Zen raised shares of Thermo Fisher Scientific from a "hold" rating to a "buy" rating in a research note on Wednesday, May 21st. Finally, Scotiabank raised Thermo Fisher Scientific from a "sector perform" rating to a "sector outperform" rating and set a $590.00 price target on the stock in a research report on Friday, July 11th. Five research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat, Thermo Fisher Scientific has a consensus rating of "Moderate Buy" and a consensus target price of $593.00.

Insider Transactions at Thermo Fisher Scientific

In other news, EVP Gianluca Pettiti sold 300 shares of the firm's stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $429.93, for a total transaction of $128,979.00. Following the sale, the executive vice president owned 23,167 shares of the company's stock, valued at approximately $9,960,188.31. This trade represents a 1.28% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is owned by corporate insiders.

Thermo Fisher Scientific Price Performance

NYSE TMO traded up $3.58 on Friday, hitting $478.61. The company had a trading volume of 4,179,842 shares, compared to its average volume of 2,512,175. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.93 and a quick ratio of 1.38. Thermo Fisher Scientific Inc. has a 12-month low of $385.46 and a 12-month high of $627.88. The company has a market capitalization of $180.67 billion, a PE ratio of 27.68, a PEG ratio of 2.25 and a beta of 0.77. The company's fifty day moving average price is $412.43 and its 200-day moving average price is $470.68.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The medical research company reported $5.36 EPS for the quarter, beating the consensus estimate of $5.22 by $0.14. Thermo Fisher Scientific had a return on equity of 16.82% and a net margin of 15.24%. The business had revenue of $10.86 billion for the quarter, compared to analyst estimates of $10.68 billion. During the same quarter in the prior year, the company posted $5.37 EPS. The company's quarterly revenue was up 2.9% on a year-over-year basis. As a group, analysts predict that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current year.

Thermo Fisher Scientific Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Monday, September 15th will be given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date of this dividend is Monday, September 15th. Thermo Fisher Scientific's dividend payout ratio is currently 10.09%.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.